A patient’s story — from self-test to treatment

James and McPhillips share specific patient cases where at-home testing changed clinical outcomes — an undiagnosed colorectal cancer catch and a same-day COVID-to-Paxlovid intervention — before pivoting toward the business case for offering these services.

James recounts a patient new to the area without an established provider who, after a conversation with him about preventive screening, took an at-home colorectal test and was diagnosed with early-stage colorectal cancer in time for successful treatment. McPhillips shares a parallel case from Episode 3, revisiting how an at-home COVID test let her quickly review a cancer patient's records, confirm Paxlovid eligibility, and prescribe it — sparing an immunocompromised, uninsured patient a costly ER visit.

Both frame these stories as evidence that at-home testing isn't only about responding to symptoms but also about catching preventive opportunities pharmacists might otherwise miss. The episode ends with the two pivoting toward a related question: how at-home testing fits into the business realities of running a community pharmacy.